Sort
15,273 grants matching “antimicrobial resistance”
INVESTIGATING TYPE VI SECRETION IN ACINETOBACTER BAUMANNII AND ITS INTERPLAY WITH ANTIBIOTIC RESISTA
$381,250Mario Feldman · Washington University · R01 · FY2020 · AI
Characterizing the role of antimicrobial peptide resistance in plague transmission
$381,250Mark A Fisher · University Of Utah · R01 · FY2020 · AI
Development of Selective Ribosomal P-site Inhibitors
$381,250Ryan Edward Looper · University Of Utah · R01 · FY2019 · AI
CHAPERONE ASSISTED PILI ASSEMBLY IN PATHOGENIC E COLI
$381,250Scott J Hultgren · Washington University · R01 · FY2016 · AI
Role of Epithelium in Immunity, Inflammation and Disease
$381,250Robert P Schleimer · Northwestern University At Chicago · R01 · FY2010 · HL
INVESTIGATING TYPE VI SECRETION IN ACINETOBACTER BAUMANNII AND ITS INTERPLAY WITH ANTIBIOTIC RESISTA
$381,250Mario Feldman · Washington University · R01 · FY2017 · AI
INVESTIGATING TYPE VI SECRETION IN ACINETOBACTER BAUMANNII AND ITS INTERPLAY WITH ANTIBIOTIC RESISTA
$381,250Mario Feldman · Washington University · R01 · FY2019 · AI
Consequences of interactions between human neutrophils and Staphylococcus aureus
$381,250William Michael Nauseef · University Of Iowa · R01 · FY2017 · AI
THE ROLE OF ESCRT IN MACROPHAGE RESISTANCE TO MYCOBACTERIA
$381,250Jennifer A Philips · Washington University · R01 · FY2015 · AI
Consequences of interactions between human neutrophils and Staphylococcus aureus
$381,250William Michael Nauseef · University Of Iowa · R01 · FY2019 · AI
THE ROLE OF ESCRT IN MACROPHAGE RESISTANCE TO MYCOBACTERIA
$381,250Jennifer A Philips · Washington University · R01 · FY2016 · AI
Role of Epithelium in Immunity, Inflammation and Disease
$381,250Robert P Schleimer · Northwestern University At Chicago · R01 · FY2011 · HL
CHAPERONE ASSISTED PILI ASSEMBLY IN PATHOGENIC E COLI
$381,250Scott J Hultgren · Washington University · R01 · FY2015 · AI
CHAPERONE ASSISTED PILI ASSEMBLY IN PATHOGENIC E COLI
$381,249Scott J Hultgren · Washington University · R01 · FY2018 · AI
Bacterial Characteristics of Community-associated Carbapenem-Resistant Enterobacteriaceae
$381,209David Van Duin · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AI
Bacterial Characteristics of Community-associated Carbapenem-Resistant Enterobacteriaceae
$381,209David Van Duin · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI
Bacterial Characteristics of Community-associated Carbapenem-Resistant Enterobacteriaceae
$381,209David Van Duin · Univ Of North Carolina Chapel Hill · R01 · FY2021 · AI
Mechanism of antibacterial activity of peptidoglycan recognition proteins
$381,150Roman Dziarski · Indiana University Indianapolis · R01 · FY2010 · AI
B-lactam mediated SOS response and expression of resistance in clinical MRSA
$381,150Adriana E Rosato · Methodist Hospital Research Institute · R01 · FY2011 · AI
B-lactam mediated SOS response and expression of resistance in clinical MRSA
$381,150Adriana E Rosato · Methodist Hospital Research Institute · R01 · FY2012 · AI
High Throughput Screens for Malaria Topoisomerases
$381,023Pradipsinh K. Rathod · University Of Washington · R01 · FY2012 · AI
Genetically Specific Therapy Against Pathogenic Bacteria
$380,988Eric G Jakobsson · University Of Illinois At Urbana-Champaign · R01 · FY2012 · GM
CHAPERONE ASSISTED PILI ASSEMBLY IN PATHOGENIC E COLI
$380,938Scott J Hultgren · Washington University · R01 · FY2014 · AI
Towards the Development of Engineered Phage Therapeutics against MDR Pathogens
$380,862Elena M Barbu · C3 Jian, Llc · R33 · FY2019 · AI
VTEU: Noninferiority Trial to Inform Treatment of Lower Respiratory Tract Infections (LRTI)
$380,862Emmanuel B Walter · Duke University · N01 · FY2018 · AI